Y-320immunomodulator CAS# 288250-47-5 |
- Fasudil (HA-1077) HCl
Catalog No.:BCC2542
CAS No.:105628-07-7
- chroman 1
Catalog No.:BCC1480
CAS No.:1273579-40-0
- GSK429286A
Catalog No.:BCC2532
CAS No.:864082-47-3
- SLx-2119
Catalog No.:BCC1954
CAS No.:911417-87-3
- AS 1892802
Catalog No.:BCC6335
CAS No.:928320-12-1
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 288250-47-5 | SDF | Download SDF |
PubChem ID | 22227931 | Appearance | Powder |
Formula | C27H29ClN6O2 | M.Wt | 505.01 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | DMSO : 5.5 mg/mL (10.89 mM; Need ultrasonic) | ||
Chemical Name | 1-(4-chlorophenyl)-N-[3-cyano-4-(4-morpholin-4-ylpiperidin-1-yl)phenyl]-5-methylpyrazole-4-carboxamide | ||
SMILES | CC1=C(C=NN1C2=CC=C(C=C2)Cl)C(=O)NC3=CC(=C(C=C3)N4CCC(CC4)N5CCOCC5)C#N | ||
Standard InChIKey | BWZNJVZTAWBIFG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C27H29ClN6O2/c1-19-25(18-30-34(19)24-5-2-21(28)3-6-24)27(35)31-22-4-7-26(20(16-22)17-29)33-10-8-23(9-11-33)32-12-14-36-15-13-32/h2-7,16,18,23H,8-15H2,1H3,(H,31,35) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Y-320 is an orally active immunomodulator and inhibitor of IL-17 production by CD4 T cells stimulated with IL-15 with IC50 of 20 to 60 nM. |
Y-320 Dilution Calculator
Y-320 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9802 mL | 9.9008 mL | 19.8016 mL | 39.6032 mL | 49.504 mL |
5 mM | 0.396 mL | 1.9802 mL | 3.9603 mL | 7.9206 mL | 9.9008 mL |
10 mM | 0.198 mL | 0.9901 mL | 1.9802 mL | 3.9603 mL | 4.9504 mL |
50 mM | 0.0396 mL | 0.198 mL | 0.396 mL | 0.7921 mL | 0.9901 mL |
100 mM | 0.0198 mL | 0.099 mL | 0.198 mL | 0.396 mL | 0.495 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Y-320 is a new phenylpyrazoleanilide immunomodulator [1].
Immunotherapy refers to treatment of disease by suppressing, inducing or enhancing an immune response.
Y-320 is a new phenylpyrazoleanilide immunomodulator. Y-320 inhibited IL-17 production by CD4 T cells induced by IL-15 with IC50 values of 20-60 nM [1].
In type II collagen-induced arthritis (CIA) mice, oral administration of Y-320 (0.3-3 mg/kg) reduced IL-17 mRNA expression and significantly inhibited the development of joint destruction and arthritis. The combination of Y-320 with anti-murine tumor necrosis factor-α (TNF-α) monoclonal antibody exhibited a synergistic effect. In cynomolgus monkeys, Y-320 (0.3-1 mg/kg) relieved CIA. These results suggested that Y-320 could be a useful candidate for therapy of rheumatoid arthritis (RA) [1].
Reference:
[1]. Ushio H, Ishibuchi S, Oshita K, et al. A new phenylpyrazoleanilide, y-320, inhibits interleukin 17 production and ameliorates collagen-induced arthritis in mice and cynomolgus monkeys. Pharmaceuticals (Basel), 2013, 7(1): 1-17.
- Phlorigidoside B
Catalog No.:BCN5189
CAS No.:288248-46-4
- 3,4-Dihydroxyphenylglycol
Catalog No.:BCN5188
CAS No.:28822-73-3
- IBMX
Catalog No.:BCC7502
CAS No.:28822-58-4
- Z-Ala-OMe
Catalog No.:BCC3056
CAS No.:28819-05-8
- SB408124
Catalog No.:BCC4972
CAS No.:288150-92-5
- Cixiophiopogon A
Catalog No.:BCN2778
CAS No.:288143-27-1
- Fraxinellone
Catalog No.:BCN1272
CAS No.:28808-62-0
- 4,7-Bis(5-bromo-2-thienyl)-2,1,3-benzothiadiazole
Catalog No.:BCC8668
CAS No.:288071-87-4
- Heraclenin
Catalog No.:BCN5187
CAS No.:2880-49-1
- Tetrazole
Catalog No.:BCC2847
CAS No.:288-94-8
- Peptone, bacteriological
Catalog No.:BCC1210
CAS No.:288-88-0
- H-Cys(Acm)-OH.HCl
Catalog No.:BCC2903
CAS No.:28798-28-9
- Denudanolide A
Catalog No.:BCN6522
CAS No.:288259-72-3
- alpha-Asarone
Catalog No.:BCN3837
CAS No.:2883-98-9
- Lithospermic acid
Catalog No.:BCN5369
CAS No.:28831-65-4
- (-)-dicentrine
Catalog No.:BCC8167
CAS No.:28832-07-7
- Cediranib (AZD217)
Catalog No.:BCC1121
CAS No.:288383-20-0
- H-Asp(OBzl)-OBzl.TosOH
Catalog No.:BCC2886
CAS No.:2886-33 -1
- S-(-)-Carbidopa
Catalog No.:BCN8453
CAS No.:28860-95-9
- Z-D-Met-OH
Catalog No.:BCC2758
CAS No.:28862-80-8
- Ergosta-5,24(28)-diene-3,7,16-triol
Catalog No.:BCN5190
CAS No.:289054-34-8
- 3,7,16-Trihydroxystigmast-5-ene
Catalog No.:BCN5191
CAS No.:289056-24-2
- Triazolam
Catalog No.:BCC5218
CAS No.:28911-01-5
- Fmoc-Cl
Catalog No.:BCC2802
CAS No.:28920-43-6
A new phenylpyrazoleanilide, y-320, inhibits interleukin 17 production and ameliorates collagen-induced arthritis in mice and cynomolgus monkeys.[Pubmed:24366113]
Pharmaceuticals (Basel). 2013 Dec 23;7(1):1-17.
Interleukin (IL)-15 and IL-17 are thought to play an important role in the pathogenesis of rheumatoid arthritis (RA) because both pro-inflammatory cytokines are found in synovial fluid of RA patients. In this study, we examined the pharmacological profiles of Y-320, a new phenylpyrazoleanilide immunomodulator. Y-320 inhibited IL-17 production by CD4 T cells stimulated with IL-15 with IC50 values of 20 to 60 nM. Oral administration of Y-320 (0.3 to 3 mg/kg) significantly inhibited the development and progression of arthritis and joint destruction with reduction of IL-17 mRNA expression in arthritic joints of type II collagen-induced arthritis (CIA) in DBA/1J mice. Y-320 in combination with anti-murine tumor necrosis factor-alpha monoclonal antibody showed a synergistic effect on mouse CIA. Moreover, therapeutic treatment with Y-320 (0.3 and 1 mg/kg orally) ameliorated CIA in cynomolgus monkeys. Our results suggest that Y-320, an orally active inhibitor for IL-17 production, provides a useful therapy for RA.